Although RAGE and its ligands are co-dependent in eliciting tumour concomitant cellular and molecular events, AGEs and RAGE can also independently facilitate tumour promotion via other non-receptor means and other ligands respectively, hence necessitating the simultaneous targeting of AGEs and RAGE duo for successful control of malignant cancers. This evidence concerns the gene AGER and neoplasm.